✦ LIBER ✦

scyllo-inositol (ELND005) ameliorates amyloid pathology in an aggressive mouse model of Alzheimer's disease

✍ Scribed by DaSilva, Kevin A.; Brown, Mary E.; Cousins, Julian E.; Rappaport, Rebecca V.; Aubert, Isabelle; Westaway, David; JoAnne McLaurin,

Book ID: 123018329
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 44 KB
Volume: 5
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2009.04.950

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Agitation and Aggression in Alzheimer's

Agitation and Aggression in Alzheimer's Disease (AD): Study Design and Outcome Measures in a Trial of Scyllo-inositol (ELND005 HARMONY AD Study)

✍ Abushakra, Susan; Bairu, M.; Kesslak, P.; Kurth, M.; Miller, D.; Lyketsos, C. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Effects of oral ELND005 (Scyllo-inositol

Effects of oral ELND005 (Scyllo-inositol) on brain scyllo-inositol and myo-inositol levels: Spectroscopy results from a phase 2 study in MILD-TO-MODERATE Alzheimer's disease

✍ Liang, Earvin; Tariot, Pierre; Abushakra, Susan; Porsteinsson, Anton; Hernandez, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Reducing Endogenous Tau Ameliorates Amyl

Reducing Endogenous Tau Ameliorates Amyloid -Induced Deficits in an Alzheimer's Disease Mouse Model

✍ Roberson, E. D.; Scearce-Levie, K.; Palop, J. J.; Yan, F.; Cheng, I. H.; Wu, T.; 📂 Article 📅 2007 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 630 KB

Imaging and cerebrospinal fluid biomarke

Imaging and cerebrospinal fluid biomarker results of a phase II dose-ranging study of ELND005 (Scyllo-inositol) in mild-to-moderate Alzheimer's disease

✍ Porsteinsson, Anton; Sperling, Reisa; Salloway, Stephen; Keren, Ron; van Dyck, C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Safety and efficacy results of a phase I

Safety and efficacy results of a phase II randomized, placebo-controlled, dose-ranging study of elnd005 (scyllo-inositol) in mild-to-moderate Alzheimer's disease

✍ Salloway, Stephen; Porsteinsson, Anton; Sperling, Reisa; Keren, Ron; van Dyck, C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Effects of oral ELND005 (scyllo-inositol

Effects of oral ELND005 (scyllo-inositol) on neuropsychiatric symptoms in a 78-week phase 2 study in mild/moderate Alzheimer's disease (AD): Potential role of myo-inositol reduction

✍ Lyketsos, Constantine; Abushakra, Susan; Liang, Earvin; Hernandez, Ramon; Tariot 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 283 KB